ArticleTargeted oncology2020

Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma.

Gabriel Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.